FDA approves second generic mifepristone from company aiming to “normalize abortion” during Kennedy’s ongoing safety review of the drug used in two-thirds of U.S. abortions.
Law requires identical generics are approved
Read the full story at USA Today
From the October 2, 2025 GovBrief, every story that day in one place.